These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19442030)

  • 1. Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse.
    Schulze JJ; Rane A; Ekström L
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):731-44. PubMed ID: 19442030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens and doping tests: genetic variation and pit-falls.
    Rane A; Ekström L
    Br J Clin Pharmacol; 2012 Jul; 74(1):3-15. PubMed ID: 22506612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of anabolic steroid abuse using a yeast transactivation system.
    Zierau O; Lehmann S; Vollmer G; Schänzer W; Diel P
    Steroids; 2008 Oct; 73(11):1143-7. PubMed ID: 18550137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of anabolic androgenic steroid abuse in doping control using mammalian reporter gene bioassays.
    Houtman CJ; Sterk SS; van de Heijning MP; Brouwer A; Stephany RW; van der Burg B; Sonneveld E
    Anal Chim Acta; 2009 Apr; 637(1-2):247-58. PubMed ID: 19286037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of isotope ratio mass spectrometry to detect doping with oral testosterone undecanoate: inter-individual variability of 13C/12C ratio.
    Baume N; Saudan C; Desmarchelier A; Strahm E; Sottas PE; Bagutti C; Cauderay M; Schumacher YO; Mangin P; Saugy M
    Steroids; 2006 May; 71(5):364-70. PubMed ID: 16438998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone in older men after the Institute of Medicine Report: where do we go from here?
    Harman SM
    Climacteric; 2005 Jun; 8(2):124-35. PubMed ID: 16096168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic steroids: what should the emergency physician know?
    Brown JT
    Emerg Med Clin North Am; 2005 Aug; 23(3):815-26, ix-x. PubMed ID: 15982547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen abuse in athletes: detection and consequences.
    Basaria S
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1533-43. PubMed ID: 20139230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase-II metabolism of androgens and its relevance for doping control analysis.
    Kuuranne T
    Handb Exp Pharmacol; 2010; (195):65-75. PubMed ID: 20020360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What is the interest of Klinefelter's syndrome for (child) psychiatrists?].
    Kebers F; Janvier S; Colin A; Legros JJ; Ansseau M
    Encephale; 2002; 28(3 Pt 1):260-5. PubMed ID: 12091788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone: use, misuse and abuse.
    Handelsman DJ
    Med J Aust; 2006 Oct; 185(8):436-9. PubMed ID: 17137434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen abuse in the community.
    Melnik BC
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):218-23. PubMed ID: 19373082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric detection of and similarities between 1-androgens.
    Verheyden K; Le Bizec B; Courtheyn D; Mortier V; Vandewiele M; Gillis W; Vanthemsche P; De Brabander HF; Noppe H
    Anal Chim Acta; 2007 Mar; 586(1-2):57-72. PubMed ID: 17386697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
    Dickerman RD; McConathy WJ; Zachariah NY
    J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.
    Schulze JJ; Lundmark J; Garle M; Skilving I; Ekström L; Rane A
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2500-6. PubMed ID: 18334593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.